Market Overview:
The global proline market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in the market can be attributed to the increasing demand for proline in pharmaceuticals, additives, and scientific research applications. North America is expected to lead the global proline market during the forecast period, followed by Europe and Asia Pacific.
Product Definition:
A nonessential amino acid that is usually synthesized in the body from glutamic acid. Proline is important for the structural stability of collagen and other proteins.
D-Proline:
D-proline, or 2-amino-1, 5 diol is a naturally occurring amino acid. It is also known as proline and written as D-pro in scientific papers. D-proline can be synthesized by both chemical and enzymatic methods.
L-Proline:
L-proline is an amino acid that is naturally found in the protein foods such as meat, eggs, and soy. It can also be manufactured by chemical synthesis or biotechnology methods. L-proline (2-1) is a white crystalline solid and has a slight odor. It freely soluble in water but because of its hydrophobic nature it gets absorbed into the skin after being applied to the surface of water hence it should be kept dry before using for pharmaceutical purpose.
Application Insights:
Proline is used in the pharmaceutical industry as an active pharmaceutical ingredient (API) for manufacturing various drugs. It is used to treat cardiovascular diseases, gastrointestinal conditions, respiratory problems and skin disorders among others. The growing demand for proline from various industries including cosmetics and personal care will drive the global market over the forecast period.
The demand for proline has increased significantly owing to its usage in producing bovine collagen products which are widely utilized as additives by several end-use industries including food & beverage processing, paper manufacturing and paints among others.
Regional Analysis:
North America dominated the global market in terms of revenue with a share of over 40.0% in 2017. This is attributed to the presence of a large number of pharmaceutical companies involved in R&D activities for drug discovery and development, which has led to an increase in demand for proline. The region is expected to witness steady growth over the forecast period owing to increasing research & development (R&D) spending by major companies such as Pfizer Inc.; Merck & Co., Inc.; and Sanofi SA.
Asia Pacific regional market captured significant share after North America due to growing population, rising disposable income levels, expanding middle-class population base along with rapid urbanization and industrialization witnessed across countries such as China, India Japan among others are anticipated boost product demand across this region over the forecast period The key manufacturers operating within Asia Pacific are Shandong Tianzhan Pharmaceuticals Co.
Growth Factors:
- Increasing demand from the automotive and construction industries as a result of growing population and rapid urbanization.
- Rising demand for Proline in the Asia Pacific region due to increasing disposable income and growth of end-user industries such as automotive, electrical & electronics, and construction.
- Growing popularity of Proline among consumers owing to its superior properties such as high strength, durability, corrosion resistance, etc.
- Technological advancements that have led to the development of new applications for Proline in various end-user industries.
Scope Of The Report
Report Attributes
Report Details
Report Title
Proline Market Research Report
By Type
D-Proline, L-Proline
By Application
Pharmaceuticals, Additives, Scientific Research
By Companies
Ajinomoto, Evonik, Kyowa Hakko, Star Lake, MEI HUA, Sigma-Alorich, Wuxi Jinhai, Bafeng Pharmaceutical, Baokang
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
238
Number of Tables & Figures
167
Customization Available
Yes, the report can be customized as per your need.
Global Proline Market Report Segments:
The global Proline market is segmented on the basis of:
Types
D-Proline, L-Proline
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Pharmaceuticals, Additives, Scientific Research
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Ajinomoto
- Evonik
- Kyowa Hakko
- Star Lake
- MEI HUA
- Sigma-Alorich
- Wuxi Jinhai
- Bafeng Pharmaceutical
- Baokang
Highlights of The Proline Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- D-Proline
- L-Proline
- By Application:
- Pharmaceuticals
- Additives
- Scientific Research
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Proline Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Proline is a nitrogen-containing organic molecule that is found in proteins, DNA, and other biomolecules. Proline can be converted into lysine by the enzyme prolyl hydroxylase.
Some of the major players in the proline market are Ajinomoto, Evonik, Kyowa Hakko, Star Lake, MEI HUA, Sigma-Alorich, Wuxi Jinhai, Bafeng Pharmaceutical, Baokang.
The proline market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Proline Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Proline Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Proline Market - Supply Chain
4.5. Global Proline Market Forecast
4.5.1. Proline Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Proline Market Size (000 Units) and Y-o-Y Growth
4.5.3. Proline Market Absolute $ Opportunity
5. Global Proline Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Proline Market Size and Volume Forecast by Type
5.3.1. D-Proline
5.3.2. L-Proline
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Proline Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Proline Market Size and Volume Forecast by Application
6.3.1. Pharmaceuticals
6.3.2. Additives
6.3.3. Scientific Research
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Proline Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Proline Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Proline Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Proline Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Proline Demand Share Forecast, 2019-2026
9. North America Proline Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Proline Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Proline Market Size and Volume Forecast by Application
9.4.1. Pharmaceuticals
9.4.2. Additives
9.4.3. Scientific Research
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Proline Market Size and Volume Forecast by Type
9.7.1. D-Proline
9.7.2. L-Proline
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Proline Demand Share Forecast, 2019-2026
10. Latin America Proline Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Proline Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Proline Market Size and Volume Forecast by Application
10.4.1. Pharmaceuticals
10.4.2. Additives
10.4.3. Scientific Research
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Proline Market Size and Volume Forecast by Type
10.7.1. D-Proline
10.7.2. L-Proline
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Proline Demand Share Forecast, 2019-2026
11. Europe Proline Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Proline Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Proline Market Size and Volume Forecast by Application
11.4.1. Pharmaceuticals
11.4.2. Additives
11.4.3. Scientific Research
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Proline Market Size and Volume Forecast by Type
11.7.1. D-Proline
11.7.2. L-Proline
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Proline Demand Share, 2019-2026
12. Asia Pacific Proline Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Proline Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Proline Market Size and Volume Forecast by Application
12.4.1. Pharmaceuticals
12.4.2. Additives
12.4.3. Scientific Research
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Proline Market Size and Volume Forecast by Type
12.7.1. D-Proline
12.7.2. L-Proline
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Proline Demand Share, 2019-2026
13. Middle East & Africa Proline Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Proline Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Proline Market Size and Volume Forecast by Application
13.4.1. Pharmaceuticals
13.4.2. Additives
13.4.3. Scientific Research
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Proline Market Size and Volume Forecast by Type
13.7.1. D-Proline
13.7.2. L-Proline
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Proline Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Proline Market: Market Share Analysis
14.2. Proline Distributors and Customers
14.3. Proline Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Ajinomoto
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Evonik
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Kyowa Hakko
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Star Lake
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. MEI HUA
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Sigma-Alorich
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Wuxi Jinhai
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Bafeng Pharmaceutical
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Baokang
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
